793
Participants
Start Date
July 31, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Budesonide/formoterol (Symbicort® Turbuhaler®)
Budesonide/formoterol (Symbicort® Turbuhaler®) 160/4.5μg/inhalation, 2 inhalations twice daily
Tiotropium (SpirivaTM)
Tiotropium (SpirivaTM) 18 μg/inhalation, 1 inhalation once daily
Research Site, Beijing
Research Site, Guangzhou
Research Site, Changsha
Research Site, Changchun
Research Site, Shenyang
Research Site, Shanghai
Research Site, Taiyuan
Research Site, Guangzhou
Research Site, Kowloon
Research Site, Hong Kong
Research Site, Hong Kong
Research Site, Jakarta
Research Site, Solo
Research Site, Surabaya
Research Site, Wŏnju
Research Site, Suwon
Research Site, Jinju
Research Site, Busan
Research Site, Daegu
Research Site, Gwangju
Research Site, Incheon
Research Site, Seoul
Research Site, Muang
Research Site, Nonthaburi
Research Site, Chiang Mai
Research Site, Bangkok
Research Site, Chon Buri
Research Site, Khon Kaen
Research Site, Phitsanulok
Research Site, Songkhla
Research Site, Udon Thani
Lead Sponsor
AstraZeneca
INDUSTRY